C/EBPbeta regulates human immunodeficiency virus 1 gene expression through its association with cdk9

J Gen Virol. 2007 Feb;88(Pt 2):631-640. doi: 10.1099/vir.0.82487-0.

Abstract

Transcriptional regulation of the human immunodeficiency virus type 1 (HIV-1) is a complex event that requires the cooperative action of both viral (e.g. Tat) and cellular (e.g. C/EBPbeta, NF-kappaB) factors. The HIV-1 Tat protein recruits the human positive transcription elongation factor P-TEFb, consisting of cdk9 and cyclin T1, to the HIV-1 transactivation response (TAR) region. In the absence of TAR, Tat activates the HIV-1 long terminal repeat (LTR) through its association with several cellular factors including C/EBPbeta. C/EBPbeta is a member of the CCAAT/enhancer-binding protein family of transcription factors and has been shown to be a critical transcriptional regulator of HIV-1 LTR. We examined whether Tat-C/EBPbeta association requires the presence of the P-TEFb complex. Using immunoprecipitation followed by Western blot, we demonstrated that C/EBPbeta-cyclin T1 association requires the presence of cdk9. Further, due to its instability, cdk9 was unable to physically interact with C/EBPbeta in the absence of cyclin T1 or Tat. Using kinase assays, we demonstrated that cdk9, but not a cdk9 dominant-negative mutant (cdk9-dn), phosphorylates C/EBPbeta. Our functional data show that co-transfection of C/EBPbeta and cdk9 leads to an increase in HIV-1 gene expression when compared to C/EBPbeta alone. Addition of C/EBP homologous protein (CHOP) inhibits C/EBPbeta transcriptional activity in the presence and absence of cdk9 and causes a delay in HIV-1 replication in T-cells. Together, our data suggest that Tat-C/EBPbeta association is mediated through cdk9, and that phosphorylated C/EBPbeta may influence AIDS progression by increasing expression of HIV-1 genes.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • CCAAT-Enhancer-Binding Protein-beta / genetics
  • CCAAT-Enhancer-Binding Protein-beta / metabolism*
  • Cell Line, Tumor
  • Cyclin T
  • Cyclin-Dependent Kinase 9 / genetics
  • Cyclin-Dependent Kinase 9 / metabolism*
  • Cyclins / genetics
  • Cyclins / metabolism
  • Gene Expression Regulation, Viral*
  • Gene Products, tat / genetics
  • Gene Products, tat / metabolism*
  • HIV-1 / pathogenicity*
  • Humans
  • Transfection
  • U937 Cells
  • tat Gene Products, Human Immunodeficiency Virus

Substances

  • CCAAT-Enhancer-Binding Protein-beta
  • CCNT1 protein, human
  • Cyclin T
  • Cyclins
  • Gene Products, tat
  • tat Gene Products, Human Immunodeficiency Virus
  • Cyclin-Dependent Kinase 9